235 related articles for article (PubMed ID: 31860337)
1. Proton beam therapy: perspectives on the National Health Service England clinical service and research programme.
Burnet NG; Mackay RI; Smith E; Chadwick AL; Whitfield GA; Thomson DJ; Lowe M; Kirkby NF; Crellin AM; Kirkby KJ
Br J Radiol; 2020 Mar; 93(1107):20190873. PubMed ID: 31860337
[TBL] [Abstract][Full Text] [Related]
2. Considerations for shoot-through FLASH proton therapy.
Verhaegen F; Wanders RG; Wolfs C; Eekers D
Phys Med Biol; 2021 Mar; 66(6):06NT01. PubMed ID: 33571981
[TBL] [Abstract][Full Text] [Related]
3. Range modulation in proton therapy planning: a simple method for mitigating effects of increased relative biological effectiveness at the end-of-range of clinical proton beams.
Buchsbaum JC; McDonald MW; Johnstone PA; Hoene T; Mendonca M; Cheng CW; Das IJ; McMullen KP; Wolanski MR
Radiat Oncol; 2014 Jan; 9():2. PubMed ID: 24383792
[TBL] [Abstract][Full Text] [Related]
4. Significance and implementation of RBE variations in proton beam therapy.
Paganetti H
Technol Cancer Res Treat; 2003 Oct; 2(5):413-26. PubMed ID: 14529306
[TBL] [Abstract][Full Text] [Related]
5. Applying a variable relative biological effectiveness (RBE) might affect the analysis of clinical trials comparing photon and proton therapy for prostate cancer.
Marteinsdottir M; Paganetti H
Phys Med Biol; 2019 Jun; 64(11):115027. PubMed ID: 31082810
[TBL] [Abstract][Full Text] [Related]
6. Comparative proton versus photon treatment planning for the Medicare Medical Treatment Overseas Program: The Royal Adelaide Hospital experience.
Hu Y; Dalfsen R; Penfold SN; Gorayski P; Tee HC; Penniment M; Le H
J Med Imaging Radiat Oncol; 2020 Oct; 64(5):682-688. PubMed ID: 32243727
[TBL] [Abstract][Full Text] [Related]
7. Clinical controversies: proton therapy for pediatric tumors.
Merchant TE
Semin Radiat Oncol; 2013 Apr; 23(2):97-108. PubMed ID: 23473686
[TBL] [Abstract][Full Text] [Related]
8. Proton beam therapy and concurrent chemotherapy for esophageal cancer.
Lin SH; Komaki R; Liao Z; Wei C; Myles B; Guo X; Palmer M; Mohan R; Swisher SG; Hofstetter WL; Ajani JA; Cox JD
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e345-51. PubMed ID: 22417808
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Patients Treated in the UK Proton Overseas Programme: Central Nervous System Group.
Gaito S; Hwang EJ; France A; Aznar MC; Burnet N; Crellin A; Holtzman AL; Indelicato DJ; Timmerman B; Whitfield GA; Smith E
Clin Oncol (R Coll Radiol); 2023 May; 35(5):283-291. PubMed ID: 36804292
[TBL] [Abstract][Full Text] [Related]
10. Hadrontherapy for cancer. An overview of HTA reports and ongoing studies.
Jefferson T; Formoso G; Venturelli F; Vicentini M; Chiarolla E; Ballini L
Recenti Prog Med; 2019 Dec; 110(12):566-586. PubMed ID: 31909760
[TBL] [Abstract][Full Text] [Related]
11. Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma.
Jones DA; Candio P; Shakir R; Ramroth J; Wolstenholme J; Gray AM; Cutter DJ; Ntentas G
Clin Oncol (R Coll Radiol); 2023 May; 35(5):301-310. PubMed ID: 36732121
[TBL] [Abstract][Full Text] [Related]
12. Child Proton Beam Therapy: A qualitative study of parental views on treatment and information sources.
H-Yazdi N; Meadows R
Radiography (Lond); 2021 Feb; 27(1):101-107. PubMed ID: 32669230
[TBL] [Abstract][Full Text] [Related]
13. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios.
Giovannini G; Böhlen T; Cabal G; Bauer J; Tessonnier T; Frey K; Debus J; Mairani A; Parodi K
Radiat Oncol; 2016 May; 11():68. PubMed ID: 27185038
[TBL] [Abstract][Full Text] [Related]
14. Toward A variable RBE for proton beam therapy.
Willers H; Allen A; Grosshans D; McMahon SJ; von Neubeck C; Wiese C; Vikram B
Radiother Oncol; 2018 Jul; 128(1):68-75. PubMed ID: 29910006
[TBL] [Abstract][Full Text] [Related]
15. Repurposing Proton Beam Therapy through Novel Insights into Tumour Radioresistance.
Chua KLM; Chu PL; Tng DJH; Soo KC; Chua MLK
Clin Oncol (R Coll Radiol); 2021 Nov; 33(11):e469-e481. PubMed ID: 34509347
[TBL] [Abstract][Full Text] [Related]
16. Normal Tissue Complication Probability Modelling for Toxicity Prediction and Patient Selection in Proton Beam Therapy to the Central Nervous System: A Literature Review.
Gaito S; Burnet N; Aznar M; Crellin A; Indelicato DJ; Ingram S; Pan S; Price G; Hwang E; France A; Smith E; Whitfield G
Clin Oncol (R Coll Radiol); 2022 Jun; 34(6):e225-e237. PubMed ID: 35042622
[TBL] [Abstract][Full Text] [Related]
17. Patterns of Proton Beam Therapy Use in Clinical Practice between 2007 and 2019 in Korea.
Lee SU; Yang K; Moon SH; Suh YG; Yoo GS
Cancer Res Treat; 2021 Oct; 53(4):935-943. PubMed ID: 34015892
[TBL] [Abstract][Full Text] [Related]
18. Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.
An Y; Shan J; Patel SH; Wong W; Schild SE; Ding X; Bues M; Liu W
Med Phys; 2017 Dec; 44(12):6138-6147. PubMed ID: 28976574
[TBL] [Abstract][Full Text] [Related]
19. Can particle beam therapy be improved using helium ions? - a planning study focusing on pediatric patients.
Knäusl B; Fuchs H; Dieckmann K; Georg D
Acta Oncol; 2016 Jun; 55(6):751-9. PubMed ID: 26750803
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
